Header

UZH-Logo

Maintenance Infos

Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine


Sigaroudi, Ali; Kullak-Ublick, Gerd A; Weiler, Stefan (2016). Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine. European Journal of Clinical Pharmacology, 72(3):377-378.

Statistics

Citations

Dimensions.ai Metrics
2 citations in Web of Science®
2 citations in Scopus®
2 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

41 downloads since deposited on 25 Oct 2016
36 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2016
Deposited On:25 Oct 2016 13:01
Last Modified:02 Feb 2018 10:32
Publisher:Springer
ISSN:0031-6970
OA Status:Green
Publisher DOI:https://doi.org/10.1007/s00228-015-1991-z
PubMed ID:26631062

Download

Download PDF  'Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 194kB
View at publisher